Mark Verratti is COO at MYRIAD GENETICS INC (MYGN). They have made 7 open-market trades across 1 company since 2012, most recently 2026-04-14.
CIK 0001517026
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $474K since 2012, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYBX | SELL | 2013-12-03 | 2013-12-05 | $71.12 | $1.3M | N/A | N/A | N/A |
| CYBX | SELL | 2013-11-27 | 2013-12-02 | $68.65 | $176K | N/A | N/A | N/A |
| CYBX | SELL | 2013-11-26 | 2013-11-29 | $68.84 | $1.1M | N/A | N/A | N/A |
| CYBX | SELL | 2013-11-25 | 2013-11-27 | $67.96 | $249K | N/A | N/A | N/A |
| CYBX | BUY | 2012-09-27 | 2012-10-01 | $37.90 | $474K | N/A | N/A | N/A |
| CYBX | SELL | 2012-09-27 | 2012-10-01 | $52.54 | $657K | N/A | N/A | N/A |
| CYBX | SELL | 2012-03-29 | 2012-04-02 | $38.25 | $80K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.